Published in Presse Med on March 17, 2001
Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet (1995) 5.77
Cardiac malformation in neonatal mice lacking connexin43. Science (1995) 5.51
Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest (1978) 4.35
Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci U S A (1977) 3.74
The regulatory light chain of nonmuscle myosin is encoded by spaghetti-squash, a gene required for cytokinesis in Drosophila. Cell (1991) 2.76
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet (2000) 2.72
Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. Lancet (1994) 2.71
Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell (1998) 2.64
Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst (1995) 2.25
Signaling events underlying thrombus formation. J Thromb Haemost (2003) 2.07
Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest (1980) 2.06
[Should man's age be a limiting factor in the ART management of the infertile couple?]. Gynecol Obstet Fertil (2007) 2.02
UNC-73 activates the Rac GTPase and is required for cell and growth cone migrations in C. elegans. Cell (1998) 2.02
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol (2001) 1.98
Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells. J Biol Chem (1987) 1.85
Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst (1992) 1.81
Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci U S A (1995) 1.75
Unusual reducing sugar from Coccidioides immitis. J Bacteriol (1970) 1.74
Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest (1997) 1.69
Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ Res (2005) 1.64
Rabbit platelet bactericidal protein. J Exp Med (1971) 1.63
Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest (1997) 1.62
Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J Cell Biol (1989) 1.59
p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer (1994) 1.58
Expanded safety study of Praneem polyherbal vaginal tablet among HIV-uninfected women in Pune, India: a phase II clinical trial report. Sex Transm Infect (2008) 1.54
Robot-assisted laparoscopic nephron sparing surgery for tumors over 4 cm: operative results and preliminary oncologic outcomes from a multicentre French study. Eur J Surg Oncol (2013) 1.53
Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med (1983) 1.49
Drosophila nonmuscle myosin II is required for rapid cytoplasmic transport during oogenesis and for axial nuclear migration in early embryos. Development (1995) 1.49
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplant (2002) 1.49
Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol Cell Biol (2001) 1.48
Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells. J Biol Chem (1978) 1.47
A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats. BJU Int (2004) 1.46
Primary cryotherapy with salvage external beam radiotherapy for locally recurrent prostate cancer. Clin Oncol (R Coll Radiol) (2008) 1.43
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res (1996) 1.43
Optimal plane for nerve sparing total mesorectal excision, immunohistological study and 3D reconstruction: an embryological study. Colorectal Dis (2013) 1.42
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst (1993) 1.42
Decrease in renal vascular resistance in University of Wisconsin solution preserved kidney transplants. J Urol (1991) 1.40
Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. J Clin Invest (1979) 1.40
Prevalence and incidence of hepatitis B virus infection in STD clinic attendees in Pune, India. Sex Transm Infect (2002) 1.37
Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res (1997) 1.35
Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology (1999) 1.32
Effect of propranolol on platelet function. Blood (1977) 1.31
The SH2 tyrosine phosphatase shp2 is required for mammalian limb development. Nat Genet (2000) 1.27
Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. J Clin Invest (1982) 1.26
Use of autologous growth factors in lumbar spinal fusion. Bone (1999) 1.26
Immunoinhibition of ristocetin-induced platelet aggregation. J Clin Invest (1977) 1.26
Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood (1998) 1.25
Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med (1997) 1.25
BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices (2013) 1.24
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C. J Viral Hepat (2011) 1.24
Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis. J Clin Invest (1987) 1.20
Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens. Eur J Hum Genet (1995) 1.19
Platelet-dependent generation of chemotactic activity in serum. J Exp Med (1973) 1.18
The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function. Circulation (1982) 1.18
Neurological manifestations of HIV disease. J Assoc Physicians India (2001) 1.18
Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res (1994) 1.17
TBX6 null variants and a common hypomorphic allele in congenital scoliosis. N Engl J Med (2015) 1.15
Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells. J Clin Invest (1981) 1.11
Perceived sources of stress amongst Indian dental students. Eur J Dent Educ (2009) 1.10
Synergistic adhesive interactions and signaling mechanisms operating between platelet glycoprotein Ib/IX and integrin alpha IIbbeta 3. Studies in human platelets ans transfected Chinese hamster ovary cells. J Biol Chem (2000) 1.10
Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Cancer Res (1999) 1.10
Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J Clin Invest (1981) 1.09
Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension (1983) 1.09
Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. Am J Physiol Heart Circ Physiol (2001) 1.09
Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease. Lancet (1977) 1.09
Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor signals through multiple pathways in endothelial cells. J Biol Chem (2001) 1.09
Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-beta variants in cells composing the cerebral vessel walls. FASEB J (2009) 1.08
Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma. Br J Cancer (2006) 1.08
Prostacyclin production by cultured endothelial cell monolayers exposed to step increases in shear stress. J Lab Clin Med (1985) 1.08
Surgical treatment of female stress urinary incontinence with a trans-obturator-tape (T.O.T.) Uratape: short term results of a prospective multicentric study. Eur Urol (2004) 1.08
Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro. Blood (1981) 1.07
A rapid fluorometric DNA assay for the measurement of cell density and proliferation in vitro. In Vitro Cell Dev Biol (1988) 1.07
Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group. Eur Urol (1998) 1.07
[What should be done in the presence of isolated microscopic hematuria in man in the work environment?]. Presse Med (1985) 1.06
The von Willebrand factor-glycoprotein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells. J Biol Chem (1999) 1.06
Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse. Leuk Lymphoma (1999) 1.05
The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone Marrow Transplant (2000) 1.04
Hemifacial microsomia: a case report. J Indian Soc Pedod Prev Dent (2008) 1.04
Generation of a chemotactic lipid from a arachidonic acid by exposure to a superoxide-generating system. Inflammation (1980) 1.04
Characterization of peptide-oligonucleotide heteroconjugates by mass spectrometry. Nucleic Acids Res (1996) 1.04
Clonal analysis of renal sporadic angiomyolipomas. Hum Pathol (1998) 1.02
Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst (1999) 1.02
Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. J Immunol (2000) 1.02
Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler Thromb (1994) 1.02
Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study. Br J Cancer (2009) 1.01
Determinants for oral hygiene and periodontal status among mentally disabled children and adolescents. J Indian Soc Pedod Prev Dent (2009) 1.01
Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders. Clin Lab Haematol (2003) 1.01
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. J Viral Hepat (2009) 1.00
8-anilino-1-naphthalene sulfonic acid (ANS) induces folding of acid unfolded cytochrome c to molten globule state as a result of electrostatic interactions. Biochemistry (1999) 0.98
Disruption of epithelial gamma delta T cell repertoires by mutation of the Syk tyrosine kinase. Proc Natl Acad Sci U S A (1996) 0.98
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Gastroenterol Clin Biol (2010) 0.98
Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Haemophilia (2005) 0.98
Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level. Birth Defects Res A Clin Mol Teratol (2004) 0.98
[Sexual side effects of pharmacological treatments]. Prog Urol (2013) 0.97